| Recent advances in exosome-based drug delivery for cancer therapy H Kim, H Jang, H Cho, J Choi, KY Hwang, Y Choi, SH Kim, Y Yang Cancers 13 (17), 4435, 2021 | 84 | 2021 |
| Taurine directly binds to oligomeric amyloid-β and recovers cognitive deficits in Alzheimer model mice HC Jang, S Lee, SL Choi, HY Kim, S Baek, YS Kim Taurine 10, 233-241, 2017 | 60 | 2017 |
| Potential of colostrum-derived exosomes for promoting hair regeneration through the transition from telogen to anagen phase H Kim, Y Jang, EH Kim, H Jang, H Cho, G Han, HK Song, SH Kim, Y Yang Frontiers in Cell and Developmental Biology 10, 815205, 2022 | 47 | 2022 |
| Harnessing the natural healing power of colostrum: bovine milk‐derived extracellular vesicles from colostrum facilitating the transition from inflammation to tissue … H Kim, DE Kim, G Han, NR Lim, EH Kim, Y Jang, H Cho, H Jang, KH Kim, ... Advanced Healthcare Materials 11 (6), 2102027, 2022 | 47 | 2022 |
| Bovine colostrum derived-exosomes prevent dextran sulfate sodium-induced intestinal colitis via suppression of inflammation and oxidative stress G Han, H Cho, H Kim, Y Jang, H Jang, ES Kim, EH Kim, KY Hwang, K Kim, ... Biomaterials Science 10 (8), 2076-2087, 2022 | 44 | 2022 |
| Comparative analyses of plasma amyloid-β levels in heterogeneous and monomerized states by interdigitated microelectrode sensor system YS Kim, YK Yoo, HY Kim, JH Roh, J Kim, S Baek, JC Lee, HJ Kim, ... Science advances 5 (4), eaav1388, 2019 | 44 | 2019 |
| The potential of cell-penetrating peptides for mRNA delivery to cancer cells Y Kim, H Kim, EH Kim, H Jang, Y Jang, SG Chi, Y Yang, SH Kim Pharmaceutics 14 (6), 1271, 2022 | 32 | 2022 |
| A Trojan-Horse Strategy by In Situ Piggybacking onto Endogenous Albumin for Tumor-Specific Neutralization of Oncogenic MicroRNA G Kwak, H Kim, J Park, EH Kim, H Jang, G Han, SY Wang, Y Yang, ... ACS nano 15 (7), 11369-11384, 2021 | 29 | 2021 |
| Oral TNF-α siRNA delivery via milk-derived exosomes for effective treatment of inflammatory bowel disease G Han, H Kim, H Jang, ES Kim, SH Kim, Y Yang Bioactive Materials 34, 138-149, 2024 | 23 | 2024 |
| Nanoparticles targeting innate immune cells in tumor microenvironment H Jang, EH Kim, SG Chi, SH Kim, Y Yang International journal of molecular sciences 22 (18), 10009, 2021 | 23 | 2021 |
| Design of PD‐L1‐Targeted Lipid Nanoparticles to Turn on PTEN for Efficient Cancer Therapy Y Kim, J Choi, EH Kim, W Park, H Jang, Y Jang, SG Chi, DH Kweon, ... Advanced Science, 2309917, 2024 | 18 | 2024 |
| RAPGEF2 mediates oligomeric Aβ‐induced synaptic loss and cognitive dysfunction in the 3xTg‐AD mouse model of Alzheimer’s disease YN Jang, HC Jang, GH Kim, JE Noh, KA Chang, KJ Lee Neuropathology and applied neurobiology 47 (5), 625-639, 2021 | 16 | 2021 |
| RNAi therapies: Expanding applications for extrahepatic diseases and overcoming delivery challenges JW Lee, MK Shim, H Kim, H Jang, Y Lee, SH Kim Advanced Drug Delivery Reviews, 115073, 2023 | 14 | 2023 |
| Post-insertion technique to introduce targeting moieties in milk exosomes for targeted drug delivery H Jang, H Kim, EH Kim, G Han, Y Jang, Y Kim, JW Lee, SC Shin, EEK Kim, ... Biomaterials Research 27 (1), 124, 2023 | 13 | 2023 |
| PDL1-binding peptide/anti-miRNA21 conjugate as a therapeutic modality for PD-L1high tumors and TAMs EH Kim, J Lee, G Kwak, H Jang, H Kim, H Cho, Y Jang, J Choi, SG Chi, ... Journal of Controlled Release 345, 62-74, 2022 | 12 | 2022 |
| Mucoadhesive Mesalamine Prodrug Nanoassemblies to Target Intestinal Macrophages for the Treatment of Inflammatory Bowel Disease B Park, G Han, DY Jin, KC Gil, D Shin, J Lee, JY Park, H Jang, D Park, ... ACS nano, 2024 | 6 | 2024 |
| Gait ignition failure in JNPL3 human tau-mutant mice HC Jang, JH Ryu, KM Shin, N Seo, GH Kim, YH Huh, AN Pae, KJ Lee Experimental Neurobiology 28 (3), 404, 2019 | 6 | 2019 |
| Taurine-Carbohydrate Derivative Stimulates Fibrillogenesis of Amyloid-β and Reduce Alzheimer-Like Behaviors HY Kim, SH Yang, J Yoon, HC Jang, S Baek, J Shin, SH Kim, YS Kim Taurine 10, 225-232, 2017 | 5 | 2017 |
| Targeted delivery of anti-miRNA21 sensitizes PD-L1high tumor to immunotherapy by promoting immunogenic cell death EH Kim, J Choi, H Jang, Y Kim, JW Lee, Y Ryu, J Choi, Y Choi, SG Chi, ... Theranostics 14 (10), 3777, 2024 | 4 | 2024 |
| Immune checkpoint-targeted drug conjugates: A promising tool for remodeling tumor immune microenvironment J Choi, H Jang, J Choi, Y Choi, Y Yang, MK Shim, SH Kim Journal of Controlled Release 359, 85-96, 2023 | 3 | 2023 |
